FDA’s Price Tag For Foreign Facility Inspections Tops $225 Million
Biennial inspections of all foreign pharmaceuticals facilities would require FDA to spend an additional $225 million per year, according to CDER Director Janet Woodcock
Biennial inspections of all foreign pharmaceuticals facilities would require FDA to spend an additional $225 million per year, according to CDER Director Janet Woodcock